In this context, it will be important to communicate the reason underpinning glucocorticoid use. Based on prior experience in patients with acute respiratory distress syndrome and those affected with SARS and MERS (5), where glucocorticoid therapy was without benefit or associated with higher rates of invasive ventilation and mortality, the World Health Organization guidance is not to prescribe glucocorticoids (6). Physiological stress doses of hydrocortisone (50–100 mg intravenously t.i.d) not pharmacological doses of other corticosteroids should be given.